Interim Dermagraft foot ulcer data fail to show significant benefits in all patients
This article was originally published in Clinica
Executive Summary
Interim results of a new clinical trial of Dermagraft for treating diabetic foot ulcers have shown that although the skin substitute healed more ulcers than the control treatment, the improvement was not statistically significant.